Evidence map›Paper›PMID 26901459›Full record

ArticleBiosensors & bioelectronics2016

Novel and simple electrochemical biosensor monitoring attomolar levels of miRNA-155 in breast cancer.

Ana R Cardoso, Felismina T C Moreira, Rúben Fernandes, M Goreti F Sales

Open access · hybridAbstract read
In one paragraph

Article in Biosensors & bioelectronics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 196 citations in OpenAlex.

  1. A Scalable Spin-Coating Strategy for Mesoporous Gold Thin Films toward miRNA Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Advancements in biosensors for cancer detection: revolutionizing diagnostics.Medical oncology (Northwood, London, England) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Fabrication of MoSMicromachines · 2023
    Article
  16. Aptasensor for the Detection ofBioengineering (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ana R CardosoBioMark-CINTESIS/ISEP, School of Engineering, Polytechnic Institute of Porto, Portugal; Molecular Mechanisms of Disease Unit, Centre of Research in Health and Environment (CISA), ESTSP-IPP, Portugal.
Felismina T C MoreiraBioMark-CINTESIS/ISEP, School of Engineering, Polytechnic Institute of Porto, Portugal.
Rúben FernandesMolecular Mechanisms of Disease Unit, Centre of Research in Health and Environment (CISA), ESTSP-IPP, Portugal; Metabolism, Nutrition and Endocrinology Unit, Integrative Cancer Programe, Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Portugal.
M Goreti F SalesBioMark-CINTESIS/ISEP, School of Engineering, Polytechnic Institute of Porto, Portugal. Electronic address: goreti.sales@gmail.com.
Polytechnic Institute of Porto · PTCentre for Health Technology and Services Research · PTi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PT

Funding

European Research Council 311086
6 · The paper itself

Abstract

This work, describes for the first time, a simple biosensing design to yield an ultrasensitive electrochemical biosensor for a cancer biomarker detection, miRNA-155, with linear response down to the attomolar range. MiRNA-155 was selected for being overexpressed in breast cancer. The biosensor was assembled in two stages: (1) the immobilization of the anti-miRNA-155 that was thiol modified on an Au-screen printed electrode (Au-SPE), followed by (2) blocking the areas of non-specific binding with mercaptosuccinic acid. Atomic force microscopy (AFM) and electrochemical techniques including cyclic voltammetry (CV), impedance spectroscopy (EIS) and square wave voltammetry (SWV) confirmed the surface modification of these devices and their ability to hybridize successfully and stably with miRNA-155. The final biosensor provided a sensitive detection of miRNA-155 from 10 aM to 1.0 nM with a low detection limit (LOD) of 5.7 aM in real human serum samples. Good results were obtained in terms of selectivity towards breast cancer antigen CA-15.3 and bovine serum albumin (BSA). Raw fluid extracts from cell-lines of melanoma did not affect the biosensor response (no significant change of the blank), while raw extracts from breast cancer yielded a positive signal against miRNA-155. This simple and sensitive strategy is a promising alternative for simultaneous quantitative analysis of multiple miRNA in physiological fluids for biomedical research and point-of-care (POC) diagnosis.

Indexed as

Biosensing TechniquesAnimalsBiomarkers, TumorBreast NeoplasmsCattleDielectric SpectroscopyElectrochemical TechniquesFemaleHumansLimit of DetectionMicroRNAsMicroscopy, Atomic ForceNucleic Acid HybridizationSerum Albumin, BovineBiomarkers, TumorMicroRNAsMIRN155 microRNA, humanSerum Albumin, BovineAnti-miRNA-155BiosensorsBreast cancerEletrochemistrymiRNA-155

Identifiers

PMID26901459
PMCPMC6366556
OpenAlexW2258571437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.